Treatment of toxic epidermal necrolysis and concurrent COVID-19-associated hyperinflammatory syndrome with systemic corticosteroids and etanercept
Saved in:
Main Authors: | Rachel Choi, MD (Author), James Garritano, PhD (Author), Mary Laird, MD (Author), Margaret Johnston, MD (Author), Elizabeth Tkachenko, MD (Author), William Damsky, MD, PhD (Author), Alicia J. Little, MD, PhD (Author), Jennifer McNiff, MD (Author), Michael Girardi, MD (Author), Caroline A. Nelson, MD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acute generalized exanthematous pustulosis simulating Stevens-Johnson syndrome/toxic epidermal necrolysis associated with the use of vismodegib
by: Oscar M. Moreno-Arrones, MD, et al.
Published: (2018) -
Relapsing toxic epidermal necrolysis following COVID-19
by: Feben Messele, BS, et al.
Published: (2024) -
Toxic epidermal necrolysis (TEN) associated with the use of nivolumab (PD-1 inhibitor) for lymphoma
by: Liezel L. Griffin, MBBS, et al.
Published: (2018) -
Treatment of necrobiosis lipoidica with combination Janus kinase inhibition and intralesional corticosteroid
by: William Damsky, MD, PhD, et al.
Published: (2020) -
Enfortumab vedotin toxic epidermal necrolysis-like blistering dermatosis: A case series and review of the literature
by: Bushra Khanjar, MD, et al.
Published: (2024)